112 related articles for article (PubMed ID: 24282985)
1. Peripheral T-cell lymphoma: time for a T-cell-centric standard of care.
Saint Fleur-Lominy S; Diefenbach CS
Oncology (Williston Park); 2013 Sep; 27(9):885-6. PubMed ID: 24282985
[No Abstract] [Full Text] [Related]
2. Peripheral T-cell lymphoma: what's the role for transplant?
Cohen JB; Flowers CR
Oncology (Williston Park); 2013 Sep; 27(9):891-2. PubMed ID: 24282986
[No Abstract] [Full Text] [Related]
3. Peripheral T-cell lymphoma: new therapeutic strategies.
Petrich AM; Rosen ST
Oncology (Williston Park); 2013 Sep; 27(9):878-84. PubMed ID: 24282984
[TBL] [Abstract][Full Text] [Related]
4. Current and novel treatment options for peripheral T-cell lymphoma.
Horwitz SM
Clin Adv Hematol Oncol; 2015 Jul; 13(7):463-6. PubMed ID: 26353042
[No Abstract] [Full Text] [Related]
5. The role of high-dose chemotherapy and autologous stem cell transplant for treatment-naΪve patients with peripheral T-cell lymphoma: a systematic review of the literature.
Jethwa KD; Bishton MJ; Fox CP
Br J Haematol; 2017 Aug; 178(3):476-479. PubMed ID: 27146257
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.
Lennard A
Br J Haematol; 2007 Apr; 137(2):170; author reply 171. PubMed ID: 17391498
[No Abstract] [Full Text] [Related]
7. Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012).
Sims MC; Newell K; Eyre TA; Hatton C; Collins GP
Br J Haematol; 2015 May; 169(3):452-5. PubMed ID: 25399667
[No Abstract] [Full Text] [Related]
8. [Diagnosis and treatment of peripheral T-cell lymphoma].
Suzumiya J; Moriyama I; Kawakami K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
[No Abstract] [Full Text] [Related]
9. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Coiffier B; Federico M; Caballero D; Dearden C; Morschhauser F; Jäger U; Trümper L; Zucca E; Gomes da Silva M; Pettengell R; Weidmann E; d'Amore F; Tilly H; Zinzani PL
Cancer Treat Rev; 2014 Oct; 40(9):1080-8. PubMed ID: 25199959
[TBL] [Abstract][Full Text] [Related]
10. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
[TBL] [Abstract][Full Text] [Related]
11. Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.
Al-Zahrani M; Savage KJ
Hematol Oncol Clin North Am; 2017 Apr; 31(2):189-207. PubMed ID: 28340873
[TBL] [Abstract][Full Text] [Related]
12. Enhancing existing approaches to peripheral T-cell lymphoma.
Foss FM
Semin Hematol; 2010 Apr; 47 Suppl 1():S8-10. PubMed ID: 20359584
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
[TBL] [Abstract][Full Text] [Related]
14. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.
Rodríguez J; Gutiérrez A; Martínez-Delgado B; Perez-Manga G
Crit Rev Oncol Hematol; 2009 Sep; 71(3):181-98. PubMed ID: 19056295
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
16. [Development of novel therapeutic agents for adult T-cell leukemia-lymphoma].
Tobinai K
Rinsho Ketsueki; 2012 Oct; 53(10):1665-74. PubMed ID: 23037739
[No Abstract] [Full Text] [Related]
17. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
18. High-dose therapy and stem cell transplantation.
Zinzani PL
Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
20. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]